Cargando…
A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV)
Pre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necessary knowledge, skills and attitudes to effectively...
Autores principales: | Wilby, Kyle J., Smith, Alesha J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356600/ https://www.ncbi.nlm.nih.gov/pubmed/32403459 http://dx.doi.org/10.3390/pharmacy8020084 |
Ejemplares similares
-
Community pharmacists’ acceptance of prescribing pre-exposure
prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: Booker, Connor, et al.
Publicado: (2023) -
Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: MacDonald, Calum B., et al.
Publicado: (2023) -
1293. The Next Step in PrEP: Evaluating Outcomes of a Pharmacist-Run HIV Pre-Exposure Prophylaxis (PrEP) Clinic
por: Ryan, Keenan, et al.
Publicado: (2018) -
Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation
por: Wagner, Gabriel A, et al.
Publicado: (2023) -
Analysis of HIV pre-exposure prophylaxis (PrEP) needs and PrEP use in Germany among men who have sex with men
por: Marcus, Ulrich, et al.
Publicado: (2022)